跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 269 条关于
“CAPOX”
全部
269
临床试验
225
药物
9
机构
0
资讯
35
去年
Alternating CAPOX/CAPIRI Plus Bevacizumab Shows Promise in Metastatic Colorectal Cancer
2年前
Osemitamab Plus Nivolumab and CAPOX Shows Encouraging Efficacy in G/GEJ Cancer
去年
Novel SHR-1701 Combination Therapy Shows Promise in Reducing Chemotherapy-Induced Myelosuppression for Gastric Cancer Patients
去年
FDA Approves Zolbetuximab for Gastric and Gastroesophageal Junction Cancer
2年前
Total Neoadjuvant Therapy Improves Outcomes in Locally Advanced Rectal Cancer
去年
Neoadjuvant SCRT Plus Camrelizumab Shows Promising 3-Year Survival in Locally Advanced Rectal Cancer
去年
Early Switch to Ramucirumab-Paclitaxel Improves Outcomes in Advanced Gastric Cancer
去年
FDA Approves Zolbetuximab for CLDN18.2-Positive Gastric and GEJ Adenocarcinoma
去年
FDA Approves Astellas' Vyloy (Zolbetuximab) for Advanced Gastric and GEJ Adenocarcinoma
10个月前
CREATE Medicines Initiates First In Vivo CAR Therapy Trial in Frontline Gastroesophageal Cancer Treatment
第 1 页,共 4 页
上一页
下一页